E2F1 and colorectal carcinoma: Considering that the pro-apoptotic effect of E2F1 depended predominantly on exogenous administration of E2F1 in vitro, and unfavorable survival in the patients with CRC who exhibited increased expression of E2F1, we speculate that the pro-proliferate effect of endogenous E2F1 might be dominant [11, 36].